Keystone eSymposia Logo

Joint meeting with HIV Pathogenesis and Cure

HIV Vaccines

June 1-4, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

Development of effective prophylactic human immunodeficiency virus (HIV) vaccines are still urgently needed to halt the spread of the HIV/AIDS pandemic. However, development of these vaccines has proven to be a challenge that, despite intensive research efforts over the last 30 years, science has failed to surmount. Nevertheless, the prospects for an effective HIV vaccine have recently been transformed by a series of advances in science. These advances suggest that induction of broadly-reactive antibodies that confer protection via neutralization and/or neutralization-independent mechanisms and elicitation of cytotoxic (CD8) T cell responses can potentially eradicate the virus early after transmission and may ultimately prove to be achievable goals for drug development. 

This conference will bring together interdisciplinary investigators whose complementary expertise will synergize to inform HIV vaccine design and evaluation to discuss progress and outstanding challenges in areas such as: 1) The design of immunogens and strategies for optimization of germinal center responses to elicit HIV-1 broadly neutralizing antibodies; 2) Identifying prospects for harnessing other antibody effector functions to confer protection; 3) Developing approaches for eliciting rapidly-acting, efficacious HIV-specific CD8 T cell responses; and 4) How to use novel technologies, animal model systems and small-scale clinical trials to inform vaccine development efforts. This conference is being held jointly with HIV Pathogenesis and Cure. This pairing will provide an opportunity for interaction between investigators working in these related areas, and for joint discussion of therapeutic vaccination strategies.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission
‣ For Short Talk Consideration: Passed
‣ For ePoster Presentation: Passed
Final ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed

*Abstract submission is required in order to submit an ePoster and/or Scitalk


Program Details

Keynote Speakers


M. Juliana McElrath
Fred Hutchinson Cancer Research Center


Bruce D. Walker
Ragon Institute of MGH, MIT and Harvard

Speaking at this eSymposia

Priyamvada Acharya

Duke University, USA

Margaret E. Ackerman

Dartmouth College, USA

Julie Ake

Walter Reed Army Institute of Research, USA

Erica Andersen-Nissen

Cape Town HVTN Immunology Laboratory, South Africa

Dan H. Barouch

Beth Israel Deaconess Medical Center, USA

Facundo D. Batista

Massachusetts Institute of Technology and Harvard University, USA

Michael R. Betts

University of Pennsylvania, USA

Persephone Borrow

University of Oxford, UK

Lawrence Corey

Fred Hutchinson Cancer Research Center, USA

Mark M. Davis

Stanford University School of Medicine, USA

Barbara K. Felber

NCI, National Institutes of Health, USA

Guillaume J. Filion

University of Toronto Scarborough, Canada

Darrell J. Irvine

Massachusetts Institute of Technology, USA

Brad Jones

Weill Cornell Medicine, USA

Nichole R. Klatt

University of Minnesota, USA

Bette Korber

Los Alamos National Laboratory, USA

M. Juliana McElrath

Fred Hutchinson Cancer Research Center, USA

Andrew J. McMichael

Oxford University, UK

Beatriz Mothe

IrsiCaixa AIDS Research Institute-HIVACAT, Spain

Hugo Mouquet

Institut Pasteur, France

Michel C. Nussenzweig

HHMI/Rockefeller University, USA

Gabriel Ozorowski

The Scripps Research Institute, USA

Louis J. Picker

Oregon Health & Science University, USA

Keith Reeves

Duke University School of Medicine, USA

Rogier W. Sanders

University of Amsterdam and Weill Cornell Medical College, Netherlands

Kevin O. Saunders

Duke University, USA

William Schief

International AIDS Vaccine Initiative and The Scripps Research Institute, USA

Robin Shattock

Imperial College London, UK

Rasmi Thomas

U.S. Military HIV Research Program, USA

Sandhya Vasan

US Military HIV Research Program, USA

Bruce D. Walker

Ragon Institute of MGH, MIT and Harvard, USA





Additional Support




Funding for this conference was made possible (in part) by Grant No. [GRANT NUMBER - UPDATE] from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Media-in-Kind Support









The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.

Donate to Keystone Symposia

Donate to Keystone Symposia